metoprolol + bisoprolol + carvedilol

This is a hypothetical combination of three beta-adrenergic receptor antagonists (beta blockers): metoprolol, bisoprolol, and carvedilol. All three are established medications used primarily in the management of cardiovascular diseases such as heart failure with reduced ejection fraction (HFrEF), hypertension, and post-myocardial infarction care. Metoprolol and bisoprolol are cardioselective beta-1 blockers, while carvedilol is a non-selective beta blocker that also blocks alpha-1 adrenergic receptors. These agents reduce heart rate, decrease myocardial contractility, lower blood pressure, and improve survival in patients with heart failure[1][2][5]. Carvedilol’s additional alpha-1 blockade leads to vasodilation. There is no evidence or clinical guideline supporting the use of all three agents simultaneously as a fixed combination; typically only one is chosen based on patient-specific factors[2][8].

Brand names

ZebetaCoregToprol XLKapspargo Sprinkle